No decision aid replaces the conversation patients should have with their clinicians to make important, clinical decisions. Use of these decision aids carries no liability to its developers or to the Mayo Clinic Foundation for Education and Research. If you download our decision aids, we would love to hear from you! Please send us a note at email@example.com to let us know who you are, why you are interested in the decision aid(s), and how you plan to use them. Remember to check back to this page periodically to make sure you are using the most up-to-date version(s).
Statin Choice decision aids use pictographs to present individualized risk of coronary events with and without the use of fixed standard dose statins.
These decision aids have been tested in a 98-patient randomized trial in specialty care and independently by another group in a primary care clinic in New York. The results of these studies are reported in the following publications:
- Nannenga MR, Montori VM, Weymiller AJ, et al. A treatment decision aid may increase patient trust in the diabetes specialist. The Statin Choice randomized trial. Health Expect 2009;12:38-44.
- Jones LA, Weymiller AJ, Shah, N. Should clinicians deliver decision aids? Further exploration of the Statin Choice randomized trial results. Med Decis Making 2009;29:468-474.
- Weymiller AJ, Montori VM, Jones LA, et al. Helping patients with type 2 diabetes mellitus make treatment decisions: Statin Choice randomized trial. Arch Intern Med 2007;167:1076-1082.
- Montori VM, Breslin M, Maleska M, Weymiller AJ. Creating a conversation: Insights from the development of a decision aid. PLoS Med 2007;4(8):233.
- Mann DM, Ponieman D, Montori VM, Arciniega J, McGinn T. The Statin Choice decision aid in primary care: a randomized trial. Patient Educ Couns 2010; 80: 138-140.
Aspirin Choice decision aids present individualized risk of coronary events with and without an aspirin regimen.
These decision aid tools are discussed in a recent publication:
- Kent DM, Shah ND. Personalizing evidence-based primary prevention with aspirin: Individualized risks and patient preferences. Circ Cardiovasc Qual Outcomes 2011;4:260-262.
Coming Soon: Hypertension Medication Choice Decision Aid
In collaboration with the SE Minnesota Beacon Program, the KER Unit is developing a decision aid to promote conversations between diabetic patients and their clinicians regarding antihypertensive medications.